Collating the findings of these reports suggests that IRF-1 may serve as a potential target for HCC treatment based on its modulatory effects upon apoptosis and autophagy; while Ki-67 may represent a valuable candidate for use in assessing LT. Here, MKI67 is linked to hepatocellular carcinoma.